Viewing Study NCT00546260


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2026-03-05 @ 9:55 PM
Study NCT ID: NCT00546260
Status: TERMINATED
Last Update Posted: 2023-08-16
First Post: 2007-10-16
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI
Sponsor: Portola Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 07-113
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Daniel Gretler, MD
Old Organization: Portola Pharmaceuticals, Inc.

Collaborators